Publications by authors named "Aditee Deshpande"

Objective: Activation of endosomal toll-like receptors (TLRs) is one possible driver of inflammation in idiopathic inflammatory myopathies (IIM). We investigated the potential contribution of TLR7 and TLR8 to IIM pathogenesis.

Methods: Activation of TLR7/8 in healthy donor peripheral blood mononuclear cells (PBMCs) by immune complexes from patients with IIMs and lupus was tested.

View Article and Find Full Text PDF

Toll-like receptor (TLR) 7 and TLR8 are transmembrane receptors that recognize single-stranded RNA. Activation of these receptors results in immune cell stimulation and inflammatory cytokine production, which is normally a protective host response. However, aberrant activation of TLR7/8 is potentially pathogenic and linked to progression of certain autoimmune diseases such as lupus.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Aditee Deshpande"

  • - Aditee Deshpande's research primarily focuses on the role of Toll-like receptors (TLRs), specifically TLR7 and TLR8, in autoimmune diseases, exploring their contributions to inflammation and disease pathogenesis in conditions like idiopathic inflammatory myopathies (IIM) and lupus.
  • - Her recent study published in 2024 investigates the activation of TLR7/8 by RNA-containing immune complexes in immune cells, aiming to understand their involvement in inflammation associated with myositis.
  • - Additionally, Deshpande's earlier work, published in 2021, highlights the discovery of M5049, a novel selective TLR7/8 inhibitor, which may offer a new therapeutic approach for managing autoimmune disorders exacerbated by aberrant TLR activation.